(Q33909569)

29 July 2017

1 reference

title

Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution (English)

1 reference

Hormone Replacement Therapy

29 July 2017

main subject

1 reference

1 reference

R J Norman

1

1 reference

29 July 2017

I H Flight

series ordinal

2

1 reference

29 July 2017

M C Rees

series ordinal

3

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

published in

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

CD001018

1 reference

Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of endurance exercise and hormone replacement therapy on serum lipids in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Treatment of postmenopausal osteoporosis with transdermal estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Change in body weight after hormone replacement therapy in postmenopausal women is dependent on basal circulating leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Comparative trial of P1496, a new non-steroidal oestrogen analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Estrogen effect on heart rate variability in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Measurement of the subcutaneous fat in the distal forearm by single photon absorptiometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Hormone replacement therapy and body size: how much does lifestyle explain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Metabolic effects of the menopause and oestrogen replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of continuous percutaneous estradiol administration on skeletal turnover in postmenopausal women: a 1-year prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Double-masked, multicenter study of an estradiol matrix transdermal delivery system (Alora) versus placebo in postmenopausal women experiencing menopausal symptoms. Alora Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Climacteric symptoms after oral and percutaneous hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Prophylaxis of osteoporosis with calcium, estrogens and/or eelcatonin: comparative longitudinal study of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Transdermal Estradiol With Oral Progestin: Biological and Clinical Effects in Younger and Older Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of a new estrogen/progestin combination in the treatment of postmenopausal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Hysterectomy, hormones, and behaviour. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

The effect of tamoxifen and transdermal 17beta-estradiol on cerebral arterial vessels: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Replacement estrogen use and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001018

10.1002/14651858.CD001018

21 January 2018

Identifiers

DOI

1 reference

release_7pw7lxxnvfhtja3t33dddgxbhe

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7pw7lxxnvfhtja3t33dddgxbhe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference